Phase 2 colorectal cancer studies
Find Phase 2 colorectal cancer trials that fit you
Every colorectal cancer study listed on this site is in Phase 2. At Colorectal Phase 2 Trials, we show you which ones are recruiting and put you in touch with a study team. The first step is a short conversation, which costs nothing and carries no obligation.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed

Phase 2 colorectal cancer studies in numbers
- Phase 2 colorectal cancer studies recruiting in the U.S.
- 91
- states with a study site
- 46
- cities with a study site
- 262
Source: ClinicalTrials.gov. Data processed .
Find Phase 2 colorectal cancer studies near you
These states have the most studies recruiting right now.
Texas
29 studies recruiting.
California
26 studies recruiting.
Florida
19 studies recruiting.
New York
18 studies recruiting.
New Jersey
15 studies recruiting.
All locations
Browse every state and city with a recruiting study.
Phase 2 colorectal cancer studies recruiting now
As of November 18, 2026, 91 Phase 2 colorectal cancer studies are recruiting participants in the United States, according to ClinicalTrials.gov. This site lists only studies that are in Phase 2, as each study is coded in the registry. This is what they have in common.
What they test
- medications80
- other approaches15
- procedures15
- radiation11
- biologics such as vaccines or antibodies7
A study can test more than one.
Main purpose
- treating a condition82
- supportive care4
- prevention3
- other purposes1
Phase
- Phase 291
Who runs them
- university, hospital or other62
- industry25
- government4
Who they enroll
- adults (18 to 64)91
- older adults (65 and over)91
Where: sites in 46 states. The cities with the most are Houston, TX (20), New York, NY (16), Los Angeles, CA (12), Nashville, TN (10), Duarte, CA (8), Baltimore, MD (7), Boston, MA (7), Chicago, IL (7).
These counts come from each study's public record and change as studies open and close. Browse every location to see what is recruiting near you.
Source: ClinicalTrials.gov. Data processed . Each bar shows a count as a share of all 91 studies.
Recently updated Phase 2 colorectal cancer studies
The 6 studies whose public records changed most recently, with some of the places each is recruiting. Select a study to read its full record on ClinicalTrials.gov.
TPST-1495 in Patients With Familial Adenomatous Polyposis
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Recruiting in
- Madison, WI · Phoenix, AZ
- Registry record
- NCT06557733 · updated
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Verastem, Inc.
- Recruiting in
- Chapel Hill, NC · Charlottesville, VA · Cleveland, OH · and 18 more U.S. locations
- Registry record
- NCT07659795 · updated
A Study of Tucatinib and Trastuzumab in People With Rectal Cancer
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Recruiting in
- Basking Ridge, NJ · Commack, NY · Harrison, NY · and 4 more U.S. locations
- Registry record
- NCT05672524 · updated
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
- Phase 2
- Ages 18 to 72
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Recruiting in
- Bethesda, MD
- Registry record
- NCT01174121 · updated
Phase II Study of Anti-PD-1/VEGF Bispecific Antibody Ivonescimab in Patients With Previously Treated Metastatic Colorectal Cancer
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- M.D. Anderson Cancer Center
- Recruiting in
- Houston, TX
- Registry record
- NCT06959550 · updated
Neoadjuvant Pembrolizumab and Porustobart in Resectable pMMR/MSS Colon Cancer
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Solstice Oncology, Inc.
- Recruiting in
- Baltimore, MD · Cleveland, OH · Los Angeles, CA · and 1 more U.S. location
- Registry record
- NCT07808151 · updated
Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in the United States on ClinicalTrials.gov.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 18, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and some of the places it is recruiting) exactly as registered. Nothing in a record is reworded. This site lists only studies that are in Phase 2, as each study is coded in the registry.
Colorectal Phase 2 Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Not sure which study fits?
Tell a coordinator what you are looking for. They will explain which Phase 2 colorectal cancer studies may be worth a closer look and what the next step is. Asking does not commit you to anything.
What Phase 2 colorectal cancer studies look at
The studies listed on this site are colorectal cancer studies in Phase 2. Each one is built around a single, specific question, which is why the visits and tasks asked of you in one Phase 2 study will not match those in another.
We describe every product under study as investigational. In practice, the word tells you that how well it performs and which risks come with it are still open questions for researchers. The study exists to answer them.
Who may be able to take part
Requirements are set study by study. For a Phase 2 colorectal cancer study they may cover your age, your past health, any medicines you are currently on, and the effect the condition has on you. Certain studies also take people who do not have the condition.
Sorting out whether you fit is not your job. A screening visit is where the study team makes that check. See how eligibility and screening work.
How taking part works
There are four steps. At each one, the choice to go on is yours.
Tell us what you are looking for
Reach us by phone or fill in the short form. We only need to know what you are looking for, whether that is the condition itself or the kind of Phase 2 study that interests you.
Talk with a coordinator
Your questions get plain-language answers from a coordinator, who also explains which studies may be a match.
Meet the study team
Should you choose to go further, you sit down with the study team for a detailed explanation of that Phase 2 study. Your eligibility is checked by them at this stage.
Decide what is right for you
Participation stays voluntary from start to finish. You are free to reconsider and withdraw from a study whenever you wish, whatever your reason.
Why people take part in Phase 2 colorectal cancer studies
People come to Phase 2 colorectal cancer studies with different reasons, and each is a sound one to talk over before you decide.
- Close follow-up of your health by a research team for the length of the study.
- A clearer picture of a condition that is part of your daily life.
- A part in answering research questions that may shape the care other people receive in years to come.
A study is research. It is not treatment, and nobody is able to tell you that joining one will benefit you yourself. Our plain-language guide covers what a clinical trial is.
Your safety and your rights come first
An independent ethics committee reviews each Phase 2 study, and enrollment cannot begin without that review. You are handed the details in writing first, and only then are you asked to agree to anything. Our guides explain how informed consent works, how studies are reviewed and monitored, and which rights you keep from beginning to end.
Common questions about Phase 2 colorectal cancer studies
Do I need a diagnosis to join a study about colorectal cancer?
There is no single answer, because each study sets this for itself. In some, a diagnosis must already be confirmed. In others, the assessment happens at screening. The study team will explain which of the two holds for the study you are considering.
Would I have to change the care I receive now?
Your existing care is not something to alter on your own. In certain Phase 2 colorectal cancer studies it carries on alongside the study, while in others it cannot. The study doctor goes through this point with you, and you are free to bring the question to your own doctor before you make a decision.
Is there a cost to take part?
In general, the visits, tests and medication that belong to a study are supplied without charge to the people taking part. Read more about costs.
Does it cost anything to ask about a study?
No. A conversation with us at Colorectal Phase 2 Trials costs you nothing, and you are not signed up for anything by asking questions.
Do I have to take part if I call?
No. At each stage the choice to carry on rests with you, and you may stop whenever you wish.
Who decides whether I can join a study?
That decision belongs to the study team, and it is made after a screening visit. Requirements differ from one study to the next. Read how screening works.
Ask about Phase 2 colorectal cancer studies
Once we have a few details from you, a coordinator will get in touch. Enquiring about a Phase 2 colorectal cancer study places you under no obligation of any kind.
Learn more from independent sources
- Colorectal Cancer — National Cancer Institute (NIH)
- What Are Clinical Trials? — National Cancer Institute (NIH)
- About Research Participation — HHS Office for Human Research Protections
- Learn About Studies — ClinicalTrials.gov (National Library of Medicine)